Results 101 to 110 of about 9,122 (206)
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T +3 more
doaj
Steroid Treatment Focused Management of Graves’ Ophthalmopathy
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H. +5 more
doaj +1 more source
Update on the medical treatment of Graves’ ophthalmopathy
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface [PDF]
core +1 more source
Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]
Yeung A +9 more
europepmc +1 more source
Correction: Extraocular muscle index as a novel indicator of inflammatory condition in graves' ophthalmopathy patients. [PDF]
Wu F +5 more
europepmc +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
Bonny M +6 more
europepmc +1 more source

